H1

2022 was a monumental year for the #healthcare industry. As we look ahead to 2023, what can we expect? From democratizing data to advancing #healthequity, we tapped into our wealth of data and insights to identify key predictions for the year ahead: https://t.co/JXSFVfzMBs

We are excited to announce that our CEO Ariel Katz has won @Techtrailblaze’s Male CxO Trailblazers Award, honoring his commitment to leadership, promotion of company diversity, and drive towards innovation: https://t.co/eyrhnO1vrt

After the FDA released guidelines on clinical trial diversity, questions arose about how exactly to take steps toward meeting these goals. Alexandra Moens, our Director of Product Marketing, offers practical advice about where to start and more: https://t.co/Ve2x9ls57D

In a post-COVID world, virtual engagements have become a normal part of life for MSLs. But moving to a more virtual or hybrid model may not make it easier to access KOLs. See the complete survey results: https://t.co/MylGPT8Hic

A recent survey conducted on behalf of @GSK found that 44% of the healthcare providers who participated pointed to the COVID-19 pandemic, among other factors, as a barrier to systemic lupus erythematosus (SLE) patients receiving the care they need.

If you’re attending the 2nd Advancing Diversity Equity & Inclusion in Pharma & Healthcare Summit next week, we hope you’ll join us on Thursday at 1:30pm for a presentation on how data can fuel trial diversity and the components critical for success. https://t.co/YfjDTFeap4

An H1 client needed to diversify its patient outreach and site investigator profiles for upcoming trials by profiling principal investigators who fit their strategic business needs for diversity & inclusion. See our client's results in this case study. https://t.co/wNPm2HjmFd

Trial Landscape offers users access to comprehensive profiles of active potential investigators. These profiles include details on both the academic and clinical experiences of investigators. Learn more: https://t.co/HWJyb8YjoF

If we were to pair SDOH data with clinical trials, ideally, we'd be able to recruit, educate and reach patients where they live. Read our latest blog post where we highlight the most requested data insights that we think can help the industry get there: https://t.co/1dIIzaao0B